The Supreme Court, on its final day of the term, declined to review a pair of high-profile cases of interest to cyberlaw attorneys -- one involving the interplay between commercial speech rights and a privacy-protective state law, the other involving copyright infringement by a cable provider's digital recording service.
The first case, Cable News Network Inc. v. CSC Holdings Inc., No 08-448 (link to lower court opinion), involved a copyright infringement challenge by a large group of television content providers against cable television service Cablevision. The Second Circuit, in proceedings below, held that Cablevision's proposed remote video recording system would not directly infringe the plaintiffs' exclusive rights in copyrighted television programming. First, the court held that each buffer copy made as data flowed through the system was transitory—stored in the DVR system for 1.2 seconds, at most—and so was not directly infringing. Second, the court held that the copies created by the Cablevision DVR service were also not directly infringing, because they were created at the direction of subscribers not Cablevision itself, which merely provided the instrumentality for making the copies.
The U.S. Solicitor General filed a brief May 29 urging the court to decline review of the case.
The second case, IMS Health Inc v. Ayotte, No. 08-1202 (link to lower court opinion), involved a First Amendment challenge to a New Hampshire law banning the sale of prescription drug information that identifies doctors' prescribing patterns. The information is useful to brand-name prescription drug marketers who want to steer doctors away from lower-cost, generic drugs. The First Circuit upheld the law. The court remarked that the New Hampshire state law regulates data transfers whose societal benefits “pale in comparison to the negative externalities produced.”
Even if the regulation does constrain protected speech, the court said, it does not violate the Constitution because it serves a substantial state interest in containing health care costs and is no more restrictive than necessary to accomplish its goals. “[W]e are not persuaded that the regulated data transfers embody restrictions on protected speech,” First Circuit Judge Bruce Selya wrote. “In our view the portions of the law at issue here regulate conduct, not speech,” he added.
The significance of the Supreme Court's denial of certiorari in any particular case is difficult to assess, well above my pay grade. Both of these cert petitions were brought by influential, well-financed businesses who predicted that dire consequences would ensue if the high court let stand the lower court's ruling. If the television content providers who brought suit in Cable News Network Inc. v. CSC Holdings Inc. really do feel they can't live with the Second Circuit's interpretation of the Copyright Act, they can get relief on Capitol Hill, and that may indeed occur.
The situation is slightly different with IMS Health Inc v. Ayotte, because that ruling has a constitutional basis. Other states may, upon seeing New Hampshire's success in turning back the drug marketers' First Amendment objections, be encouraged to enact similar laws. Drug marketers might be able to persuade Congress to preempt state laws like the one at issue in IMS Health v. Ayotte. Short of this, however, the only place for drug marketers to get relief on the First Amendment question is in the federal courts, perhaps the Supreme Court, at some later date.
Recent Comments